SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Diana, Princess of Wales — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientDiana Spencer
Date of birth1961-07-01
IdentifiersMRN HR-ML028-SYN-TD; SSN (made up) 000-28-5197
Document date1990-05-11
AuthorImogen Castleford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Three-month review: binge and purge frequency, electrolytes, dental care, mood, and safety. [S]

History of Present Illness

Ms. Spencer returns three months after her first visit. She has had sixteen CBT-E sessions and is now working with her therapist on her concerns about shape and weight and on binges that follow difficult days. She has had two episodes of binge eating with vomiting in the last four weeks, both after long working days. She eats three meals and two snacks on six or seven days a week. She saw a dentist three weeks ago: the erosion was confirmed, a fluoride varnish was applied, no new decay was found, and a review was set for six months. She takes fluoxetine 60 mg each morning and an over-the-counter folic acid tablet. She completed the mid-treatment EDE-Q with her therapist. Her mood is good and she has had no thoughts of suicide or self-harm. [S]

ElementDetail
Binge eating and vomitingTwo episodes in the last four weeks
CBT-ESixteen sessions; weekly
Regular eatingThree meals and two snacks on six or seven days a week
Dental examinationDone three weeks ago; fluoride varnish; review in six months
MoodGood; PHQ-9 5; item 9 scored 0

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy good; weight steady
GastrointestinalNegativeTwo episodes of vomiting in four weeks; no heartburn or abdominal pain
Ears, nose, mouth, and throatNegativeTooth sensitivity better since the varnish
PsychiatricNegativeMood good; no thoughts of suicide or self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Potassium chloride 20 mEq extended-release oral tablet, one tablet by mouth twice daily with foodOne tablet by mouth twice daily with food, swallowed whole with a full glass of waterOral route1990-02-09 to 1990-03-16completedS
Fluoxetine 20 mg oral capsule, one capsule by mouth each morning for one week, then two capsules each morning for one weekOne capsule each morning for one week, then two capsules each morning for one weekOral route1990-02-16 to 1990-03-02completedS
Fluoxetine 60 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route1990-03-02activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1990-05-11Body height178cmS
1990-05-11Body weight62kgS
1990-05-11Body mass index (BMI) [Ratio]19.6kg/m2S
1990-05-11Systolic blood pressure108mm[Hg]S
1990-05-11Diastolic blood pressure68mm[Hg]S
1990-05-11Heart rate68/minS
1990-05-11Respiratory rate14/minS
1990-05-11Body temperature36.6CelS
1990-05-11Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1990-05-11Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1990-05-11Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
1990-05-11Chloride [Moles/volume] in Serum or Plasma102mmol/L98-107 mmol/LNormalS
1990-05-11Carbon dioxide, total [Moles/volume] in Serum or Plasma25mmol/L22-29 mmol/LNormalS
1990-05-11Creatinine [Mass/volume] in Serum or Plasma0.79mg/dL0.59-1.04 mg/dLNormalS
1990-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1985)/1.73 sq M104mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1990-05-11Amylase [Enzymatic activity/volume] in Serum or Plasma88U/L28-100 U/LNormalS
1990-05-11Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S

Physical Exam

Vital signs recorded on 1990-05-11; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 62.0 kg, BMI 19.6; lying blood pressure 108/68 and pulse 68, standing 108/70 and pulse 76 after three minutes
Head and neckParotid glands now barely enlarged; enamel erosion stable
SkinKnuckle calluses gone
PsychiatricEuthymic and engaged; organized

Problems

ProblemClinical statusVerificationCodeProvenance
Bulimia nervosa, severe: recurrent binge eating, each time with self-induced vomiting, averaging about ten episodes a week for about three years, hidden from everyone; self-worth tied closely to body shape and weight; no laxatives, diuretics, diet pills, or excessive exercise. SCOFF 4 of 5; EDE-Q global score 3.9. Findings: bilateral parotid enlargement, enamel erosion on the inner surfaces of the upper front teeth, calluses on the backs of two knuckles of the right hand, a pulse rise of 22 per minute on standing, low potassium and chloride with a raised bicarbonate, and a raised amylase; BMI 19.3. Synthetic modern episode linked to her own public account of bulimiaactiveconfirmed F50.23S — Synthetic modern diagnosis by DSM-5-TR criteria; severity is graded by the average number of compensatory episodes a week (8 to 13 is severe).
Hypokalemia (potassium 3.1 mmol/L) with low chloride and metabolic alkalosis from repeated vomiting; QTc 452 ms; no palpitations, weakness, or faintingresolvedconfirmed E87.6S — Synthetic presenting laboratory finding; resolved when potassium was normal on two checks.
Major depressive disorder, recurrent, moderate: about two months of low mood, tiredness, poor sleep, and feeling worthless and hopeless, with little pleasure in things she used to enjoy; PHQ-9 14 with item 9 scored 0; an earlier episode of depression after childbirth. Synthetic modern episode linked to her own public account of depressionactiveconfirmed F33.1S — Synthetic modern diagnosis; the earlier episode is the post-natal depression she described publicly.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyBinge-eating and vomiting frequency (her self-monitoring record)Every visitCompleted todayTwo episodes in the last four weeks
SurveyEating Disorder Examination Questionnaire (EDE-Q) global scoreBaseline, mid-treatment, and end of treatmentCompleted todayGlobal score 2.1 at mid-treatment, from 3.9
ExaminationWeight and BMIEvery visit, and weekly in CBT-E sessionsCompleted today62.0 kg, BMI 19.6
ExaminationLying and standing pulse and blood pressureEvery visit while purging continuesCompleted todayLying 108/68, pulse 68; standing 108/70, pulse 76 (rise 8)
LaboratoryPotassium, chloride, bicarbonate, and creatinineWeekly until potassium is normal twice, then at each medical visit while purging continuesCompleted todayPotassium 4.1 mmol/L off supplements; sodium 139, chloride 102, bicarbonate 25 mmol/L; creatinine 0.79 mg/dL, eGFR 104
LaboratoryAmylaseBaseline with parotid enlargement; repeat as indicatedCompleted today88 U/L, from 146 at intake
LaboratoryECG with QTcBaseline with purging or low potassium; after a QT-relevant medicine reaches its full dose while potassium has been lowNot indicatedQTc 441 ms on fluoxetine 60 mg with normal potassium; no further routine ECG unless symptoms, low potassium, or a new QT-relevant medicine
ExaminationParotid and dental examination; dental protectionEvery visit; a dental examination soon after diagnosis and regular dental reviews while vomiting continuesCompleted todayDental examination done three weeks ago, about ten weeks after it was advised at intake; erosion stable, fluoride varnish, no new decay, review in six months. The delay is closed; no harm resulted
Medication safetyFluoxetine dose, adherence, and side effects (nausea, sleep, agitation, sexual effects, suicidal thoughts)At the start, one to two weeks after starting or a dose change, then every visitCompleted today60 mg; no side effects; no agitation or suicidal thoughts
Self-managementCBT-E attendance and progressUp to 20 sessions over 20 weeks, twice weekly for the first four weeksCompleted todaySixteen sessions; weekly
Self-managementRegular eating and dietitian reviewEvery visitCompleted todayThree meals and two snacks on six or seven days a week
SurveyDepression measure (PHQ-9)Monthly during acute treatment, then periodicallyCompleted todayPHQ-9 5, item 9 scored 0
SurveySuicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; safety plan current

Goal progress:

Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Eating disorders: recognition and treatment (NICE guideline NG69) (2017, updated 2020); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: CBT-E weekly to session 20. End-of-treatment review in about nine weeks with electrolytes, the EDE-Q, and the PHQ-9. Next scheduled visit 1990-07-13: end-of-treatment review after 20 weeks of CBT-E: remission, relapse prevention, and continuing fluoxetine. [S]